practolol has been researched along with warfarin in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (30.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (30.00) | 29.6817 |
2010's | 4 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Caron, G; Ermondi, G | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Du-Cuny, L; Mash, EA; Meuillet, EJ; Moses, S; Powis, G; Song, Z; Zhang, S | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Barber, S; Dew, TP; Farrell, TL; Poquet, L; Williamson, G | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Kumakura, S; Oshima, T | 1 |
Härich, B; Hassis, R; Immich, H; Jeschke, D; Kutscha, W; Schaumann, HJ; Stauch, M; Tschirdewahn, B | 1 |
Azarnoff, DL | 1 |
1 trial(s) available for practolol and warfarin
Article | Year |
---|---|
[Clinical studies on the effect of drugs used in the treatment of angina].
Topics: Adult; Aged; Amino Alcohols; Angina Pectoris; Blood Pressure; Clinical Trials as Topic; Coumarins; Evaluation Studies as Topic; Female; Glycolates; Heart Rate; Humans; Isosorbide Dinitrate; Male; Middle Aged; Phenethylamines; Practolol; Propiophenones; Pulse | 1975 |
9 other study(ies) available for practolol and warfarin
Article | Year |
---|---|
Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk).
Topics: 1-Octanol; Alkanes; Hydrogen-Ion Concentration; Least-Squares Analysis; Mathematics; Models, Chemical; Models, Molecular; Solvents; Water | 2005 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.
Topics: Antineoplastic Agents; Blood Proteins; Caco-2 Cells; Cell Membrane Permeability; Computer Simulation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Phosphoproteins; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Predicting phenolic acid absorption in Caco-2 cells: a theoretical permeability model and mechanistic study.
Topics: Artificial Intelligence; Caco-2 Cells; Cell Membrane Permeability; Cinnamates; Enterocytes; Humans; Hydrophobic and Hydrophilic Interactions; Intestinal Absorption; Kinetics; Models, Biological; Molecular Conformation; Osmolar Concentration; Phenols | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Effects of beta blockers on cardiac function and myocardial oxygen consumption in the isolated supported heart preparation of the dog.
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Coumarins; Depression, Chemical; Dogs; Female; Heart; Heart Rate; In Vitro Techniques; Male; Myocardium; Oxygen Consumption; Practolol; Propanolamines | 1975 |
Application of blood level data to clinical trials.
Topics: Alkylating Agents; Biopharmaceutics; Disease; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy; Environment; Genetics; Half-Life; Heart; Heart Rate; Hemodynamics; Humans; Isoproterenol; Patients; Pharmaceutical Preparations; Practolol; Propranolol; Protein Binding; Receptors, Drug; Warfarin; Water-Electrolyte Balance | 1974 |